Next Article in Journal
Escitalopram Dose Optimization During Pregnancy: A PBPK Modeling Approach
Previous Article in Journal
Development of Co-Amorphous Systems for Inhalation Therapy—Part 2: In Silico Guided Co-Amorphous Rifampicin–Moxifloxacin and –Ethambutol Formulations
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(10), 1340; https://doi.org/10.3390/pharmaceutics17101340
Action Date Notes Link
article html file updated 17 October 2025 10:32 CEST Update https://www.mdpi.com/1999-4923/17/10/1340/html
article pdf uploaded. 17 October 2025 10:30 CEST Updated version of record https://www.mdpi.com/1999-4923/17/10/1340/pdf
article xml uploaded. 17 October 2025 10:30 CEST Update https://www.mdpi.com/1999-4923/17/10/1340/xml
article xml file uploaded 17 October 2025 10:30 CEST Update -
article html file updated 17 October 2025 09:25 CEST Original file -
article pdf uploaded. 17 October 2025 09:23 CEST Updated version of record https://www.mdpi.com/1999-4923/17/10/1340/pdf-vor
article xml uploaded. 17 October 2025 09:23 CEST Update -
article xml file uploaded 17 October 2025 09:23 CEST Original file -
article supplementary file uploaded. 16 October 2025 15:28 CEST - https://www.mdpi.com/1999-4923/17/10/1340#supplementary
article pdf uploaded. 16 October 2025 15:28 CEST Version of Record https://www.mdpi.com/1999-4923/17/10/1340/pdf-vor
Back to TopTop